Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
Beijing Friendship Hospital
NGM Biopharmaceuticals, Inc
IRCCS Ospedale San Raffaele
European Institute of Oncology
Association Francaise pour la Recherche Thermale
Universitair Ziekenhuis Brussel
SpotitEarly
University Hospital, Ghent
Uppsala University
University Medical Center Groningen
Novosanis NV
Massachusetts General Hospital
Lebanese University
Infinity Pharmaceuticals, Inc.
Kineta Inc.
Namida Lab
Université Sorbonne Paris Nord
MiRXES Pte Ltd
Jules Bordet Institute
Impact Therapeutics, Inc.
Blue Note Therapeutics
Boston VA Research Institute, Inc.
Imperial College London
Hospital de Clinicas de Porto Alegre
Assistance Publique - Hôpitaux de Paris
Weprom
Shanghai Fengxian District Central Hospital
Instituto de Investigacion Sanitaria La Fe
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
Hamilton Health Sciences Corporation
Charite University, Berlin, Germany
SpeciCare
Instituto Portugues de Oncologia, Francisco Gentil, Porto
Chinese University of Hong Kong
Sun Yat-sen University
Samyang Biopharmaceuticals Corporation
Instituto do Cancer do Estado de São Paulo
The University of The West Indies
Taizhou EOC Pharma Co., Ltd.
Royal Marsden NHS Foundation Trust
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
KU Leuven
Placon Therapeutics
Quantgene Inc.
Maastricht University Medical Center
Wuxi No. 4 People's Hospital
Optimata Ltd.
Sun Yat-sen University
Shenzhen Second People's Hospital